News

2019

company

year

domain

Growth at Flagship Pioneering Leads to New Executive Appointments

Flagship Pioneering 05.28.2019

With Microbiome Technology, Expanded Market Access, and Season-Long Support, Growers Earn Up to an Additional $59 per Acre with 2020 Indigo Certified Wheat™

Indigo Agriculture 05.22.2019

Quanterix Announces $50,000 In Grants to Support Promising Oncology Research

Quanterix 05.16.2019

Moderna Announces Publication of Phase 1 Data for mRNA Vaccines Against Two Potential Pandemic Influenza Strains

Moderna 05.10.2019

New Publication in Cancer Research Highlights Discovery of SY-1365, a First-in-Class Selective CDK7 Inhibitor, and its Promise as a Potentially Transformative Targeted Approach for Difficult-to-Treat Cancers

Syros Pharmaceuticals 05.07.2019

MIT Solve Announces Launch of Solve Innovation Fund

Flagship Pioneering 05.07.2019

TARIS Bio Initiates New Clinical Study of TAR-302 in Overactive Bladder

TARIS Biomedical 05.01.2019

Kintai’s Host-Targeting Niche in Flagship Microbiome Ecosystem

04.16.2019

Flagship Unveils Gut-Focused Upstart Kintai, with Former GSK Exec as Chief

04.16.2019

Flagship Pioneering Unveils Kintai Therapeutics and Appoints Pharmaceutical Drug Developer Paul-Peter Tak, M.D., Ph.D., as Chief Executive Officer

Flagship Pioneering 04.16.2019

Loading